Skip to Content

Zhejiang Guobang Pharmaceuticals, China, 2022

GMP Audit Report

Company
Zhejiang Guobang Pharmaceuticals

Product(s)
Enrofloxacin

Country
China

Audit Year
2022

0.00 € 0.00 €
0.00 €